Fermenta Biotech Limited (BOM:506414)

India flag India · Delayed Price · Currency is INR
332.40
+7.00 (2.15%)
At close: Mar 9, 2026
17.79%
Market Cap 9.78B
Revenue (ttm) 5.44B
Net Income (ttm) 869.65M
Shares Out 29.43M
EPS (ttm) 29.54
PE Ratio 11.25
Forward PE n/a
Dividend 2.50 (0.77%)
Ex-Dividend Date Aug 6, 2025
Volume 23,496
Average Volume 22,181
Open 323.00
Previous Close 325.40
Day's Range 312.20 - 337.00
52-Week Range 240.00 - 399.00
Beta -0.19
RSI 54.46
Earnings Date Feb 9, 2026

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional sup... [Read more]

Industry Pharmaceutical Preparations
Founded 1951
Employees 606
Stock Exchange Bombay Stock Exchange
Ticker Symbol 506414
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.